Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Hereditary cerebral small vessel disease and stroke

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Adaptive hybrid surgery analysis (AHSA) for adjuvant gamma knife radiosurgery treatment of vestibular schwannoma residuals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Long-term functional outcome after decompressive suboccipital craniectomy for space-occupying cerebellar infarction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Expanding the phenotype of filamin-C-related myofibrillar myopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Implication of using MRI co-registered with CT in Leksell Gamma Knife(®) dose planning for patients with vestibular schwannoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Organisering af Perifer Nervekirurgi i Danmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clinical and genetic characteristics of late-onset Huntington's disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Peripheral neuropathy in hereditary spastic paraplegia caused by REEP1 variants

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Inflammatory markers of CHMP2B-mediated frontotemporal dementia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Cerebral small vessel disease is considered hereditary in about 5% of patients and is characterized by lacunar infarcts and white matter hyperintensities on MRI. Several monogenic hereditary diseases causing cerebral small vessel disease and stroke have been identified. The purpose of this systematic review is to provide a guide for determining when to consider molecular genetic testing in patients presenting with small vessel disease and stroke. CADASIL, CARASIL, collagen type IV mutations (including PADMAL), retinal vasculopathy with cerebral leukodystrophy, Fabry disease, hereditary cerebral hemorrhage with amyloidosis, and forkhead box C1 mutations are described in terms of genetics, pathology, clinical manifestation, imaging, and diagnosis. These monogenic disorders are often characterized by early-age stroke, but also by migraine, mood disturbances, vascular dementia and often gait disturbances. Some also present with extra-cerebral manifestations such as microangiopathy of the eyes and kidneys. Many present with clinically recognizable syndromes. Investigations include a thorough family medical history, medical history, neurological examination, neuroimaging, often supplemented by specific examinations e.g of the of vision, retinal changes, as well as kidney and heart function. However molecular genetic analysis is the final gold standard of diagnosis. There are increasing numbers of reports on new monogenic syndromes causing cerebral small vessel disease. Genetic counseling is important. Enzyme replacement therapy is possible in Fabry disease, but treatment options remain overall very limited.

OriginalsprogEngelsk
TidsskriftClinical Neurology and Neurosurgery
Vol/bind155
Sider (fra-til)45-57
Antal sider13
ISSN0303-8467
DOI
StatusUdgivet - 22 feb. 2017

ID: 50120470